By elucidating the mechanism responsible for the neurodegeneration and dementia seen in people infected with HIV, the findings made in mice that produce the damaging HIV protein may open the door to new therapies, according to the researchers.
“The breakthrough here is that the AIDS virus prevents stem cells in the brain from dividing; it hangs them up,” said Stuart Lipton of the Burnham Institute for Medical Research and the University of California at San Diego. “It’s the first time that the virus has ever been shown to affect stem cells.”
“It’s a double hit to the brain,” added collaborator Marcus Kaul, who is also of the Burnham Institute and UCSD. “The HIV protein both causes brain injury and prevents its repair.”
Physicians first recognized that HIV infection could lead to a profound form of dementia—most commonly in those with an advanced stage of the disease—early on. The success of antiretroviral therapies in keeping the “viral load” down has helped to reduce the severity of the dementia in recent years. Nonetheless, the prevalence is rising as HIV-infected people are living longer. The anti-HIV drugs don’t infiltrate the brain well, allowing for a “secret reservoir” of virus, Lipton explained. Such persistent exposure of the central nervous system to HIV is a major risk factor for the development of HIV-associated dementia.
Lipton’s team previously discovered that the brain deficits could be triggered by gp120—the viral coat protein that latches onto human cells—even in the absence of any viral infection. They also showed that the protein disrupts a key cell-cycle pathway (including p38 mitogen-activated protein kinase or MAPK), leading to the death of certain mature neurons.
The researchers now find that gp120 in mice also slows the production of new neurons in the hippocampus, a brain region central to learning and memory. Newborn neurons become integrated into existing brain circuits and are thought to contribute to certain forms of learning and memory, they said.
Moreover, they found that it is the same MAPK pathway earlier linked to the death of mature neurons that lies at the root of the progenitor cells’ dysfunction. That a similar enzyme is involved in both brain-damaging effects is simply “serendipitous,” according to the researchers.
“Knowing the mechanism, we can start to approach this therapeutically,” Lipton said. “This indicates that we might eventually treat this form of dementia by either ramping up brain repair or protecting the repair mechanism,” Kaul added.
Source: Cell Press
Related stories:
Molecular changes in brain fluid give insight into brain-damaging disease
Soon after an individual becomes infected with HIV the virus infects cells in the brain and spinal cord (the central nervous system [CNS]). Although this causes no immediate problems, during the late-stages of disease it can cause dementia and encephalitis (acute inflammation of the brain that can cause death).
Computer game's high score could earn the Nobel Prize in medicine
Gamers have devoted countless years of collective brainpower to rescuing princesses or protecting the planet against alien invasions. This week researchers at the University of Washington will try to harness those finely honed skills to make medical discoveries, perhaps even finding a cure for HIV.
Researchers discover how stealthy HIV protein gets into cells
Scientists have known for more than a decade that a protein associated with the HIV virus is good at crossing cell membranes, but they didn’t know how it worked. A multidisciplinary team from the University of Illinois has solved the mystery, and their findings could improve the design of therapeutic agents that cross a variety of membrane types. A paper describing their findings appears this month in
Angewandte Chemie.
Anti-parasite drug may provide new way to attack HIV
A drug already used to treat parasitic infections, and once looked at for cancer, also attacks the human immunodeficiency virus (HIV) in a new and powerful way, according to research published today online in the open access journal
Retrovirology.
T-cell 'nanotubes' may explain how HIV virus conquers human immune system
String-like connections found between T-cells could be important to how HIV spreads between cells in the human immune system, according to new research published online yesterday in
Nature Cell Biology. The newly-discovered strands, named 'membrane nanotubes' by scientists, could help to explain how the HIV virus infects human immune cells so quickly and effectively.
MicroRNAs may be key to HIV's ability to hide, evade drugs
Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Researchers at Jefferson Medical College in Philadelphia have shown that when an individual infected with HIV receives a powerful cocktail of antiviral agents called HAART (highly active antiretroviral therapy), the virus calls on miRNAs to help it remain quiet and practically undetectable, temporarily shutting down its ability to replicate and infect.
Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage
Work proceeding rapidly toward application for human trials
Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published today in the journal Arthritis and Rheumatism. While the study was done in mice, they are the first genetically engineered to develop osteoarthritis like humans, with the same genetic predisposition that makes some more likely to develop the disease, the authors said. If all goes well with a follow-up study currently underway, researchers will apply to the U.S. Food and Drug Administration for permission to begin human trials next year.
Toxoplasmosis infection trick revealed by scientists
Toxoplasmosis is a parasitic disease, primarily carried by cats. It is transmitted to humans by eating undercooked meat or through contact with cat faeces. It is particularly dangerous for pregnant women, whose foetuses can be infected via the placenta, and those with a weakened immune system, such as people infected with HIV. In severe cases, toxoplasmosis can cause damage to the brain and eyes, and even death.